No Medicare Clawbacks Act of 2026
Key claim: The No Medicare Clawbacks Act of 2026 (HR9532) would address Medicare clawback practices and has been referred to the House Ways and Means and Energy and Commerce committees.
Abstract
(HR9532 · 119th Congress) Latest action (2026-06-29): Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Why this matters
Medicare clawbacks — retroactive recoupments from providers or plans — can affect provider cash flow and pharmacy reimbursement, particularly in Part D and Medicare Advantage contexts. Legislation constraining these practices could shift financial risk between CMS, plans, pharmacies, and providers, though the practical impact will depend on legislative text that is not yet public at referral stage.